Vimarsana
Biggest News Aggregation in the World

Page 31 - Teddy Whiley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Teddy Whiley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Teddy Whiley Today - Breaking & Trending Today

ANGLE plc: Angle PLC Announces Exercise of options and total voting rights - Vimarsana News

ANGLE plc: Angle PLC Announces Exercise of options and total voting rights

ANGLE plc: Angle PLC Announces Exercise of options and total voting rights GUILDFORD, SURREY / ACCESSWIRE / May 19, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and allotted 216,000 new Ordinary shares of £0.10 each ("New Ordinary Shares") in the Company. The New Ordinary Shares rank pari passu with the existing Ordinary shares in the Company. An application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM (" Admission") and it is ...

Investegate |Angle PLC Announcements | Angle PLC: Exercise of options and total voting rights - Vimarsana News

Investegate |Angle PLC Announcements | Angle PLC: Exercise of options and total voting rights

About ANGLE plc www.angleplc.com ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLE's proven patent protected platforms include a circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.   ANGLE's cell separation technology is called the Parsortix ®   system, and it enables a liquid biopsy (a simple blood test) to be used to provide the cells of interest to the user in a format suitable for mu...

Investegate |Angle PLC Announcements | Angle PLC: Parsortix study uncovers targets in TNBC patients - Vimarsana News

Investegate |Angle PLC Announcements | Angle PLC: Parsortix study uncovers targets in TNBC patients

About ANGLE plc   www.angleplc.com   ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLE's proven patent protected platforms include a circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.   ANGLE's cell separation technology is called the Parsortix ® system, and it enables a liquid biopsy (a simple blood test) to be used to provide the cells of interest to the user in a format suitable for multiple ty...

Revolution Bars Group PLC (AIM:RBG) | RNS | Revolution Bars - Vimarsana News

Revolution Bars Group PLC (AIM:RBG) | RNS | Revolution Bars

Re-opening Update Revolution Bars Group plc ("the Group" or "the Company"), a leading operator of 66 premium bars, trading under the Revolution and Revolucion de Cuba brands, welcomes the comments by the Prime Minister, Boris Johnson on England, further easing restrictions to allow indoor trading of our bars on 17 May 2021 and confirming that the Roadmap remains on track for a return to restriction free trading on 21 June 2021. 13 April 2021, the Company was excited to be able to recommence trading outside on 12 April 2021 in 20 bars, ready to bounce back to capture the pent-up demand an...

ANGLE plc: Angle PLC Announces Exercise of Options and Total Voting Rights - Vimarsana News

ANGLE plc: Angle PLC Announces Exercise of Options and Total Voting Rights

ANGLE plc: Angle PLC Announces Exercise of Options and Total Voting Rights SURREY, UK / ACCESSWIRE / April 30, 2021 / ANGLE plc (AIM: AGL OTCQX: ANPCY), a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and allotted 203,333 new Ordinary shares of £0.10 each ("New Ordinary Shares") in the Company. The New Ordinary Shares rank pari passu with the existing Ordinary shares in the Company. An application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM (" Admission") and it is expe...